Andrey I Egorov1, Reagan R Converse2, Shannon M Griffin3, Jennifer N Styles2,4, Elizabeth Sams2, Edward Hudgens2, Timothy J Wade2. 1. United States Environmental Protection Agency, Office of Research and Development, EPA, MD 58-C, 109. T.W. Alexander Drive, Research Triangle Park, NC, 27711, USA. egorov.andrey@epa.gov. 2. United States Environmental Protection Agency, Office of Research and Development, EPA, MD 58-C, 109. T.W. Alexander Drive, Research Triangle Park, NC, 27711, USA. 3. United States Environmental Protection Agency, Office of Research and Development, Cincinnati, OH, USA. 4. Gillings School of Global Public Health, Environmental Sciences and Engineering Department, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract
BACKGROUND: Toxoplasma gondii is a protozoan parasite that infects cats as definitive hosts and other warm-blooded animals including humans as intermediate hosts. It forms infectious cysts in the brain, muscle and other tissues establishing life-long latent infection. Approximately 10% of the US population is infected. While latent infections are largely asymptomatic, they are associated with neurological deficits and elevated risks of neuropsychiatric diseases. METHODS: This cross-sectional epidemiological study investigated associations of T. gondii infections with biomarkers of inflammation and vascular injury: soluble intercellular adhesion molecule 1 (ICAM-1), soluble vascular cell adhesion molecule 1 (VCAM-1), C-reactive protein (CRP), and serum amyloid A (SAA). Serum samples from 694 adults in the Raleigh-Durham-Chapel Hill, North Carolina metropolitan area were tested for IgG antibody response to T. gondii, and for the above biomarkers using commercially available assays. RESULTS: T. gondii seroprevalence rate in this sample was 9.7%. Seropositivity was significantly associated with 11% (95% confidence limits 4, 20%) greater median levels of VCAM-1 (p = 0.003), and marginally significantly with 9% (1, 17%), and 36% (1, 83%) greater median levels of ICAM-1, and CRP, respectively (p = 0.04 for each) after adjusting for sociodemographic and behavioral covariates, while the 23% (- 7, 64%) adjusted effect on SAA was not statistically significant (p = 0.15). CONCLUSIONS: Latent infections with T. gondii are associated with elevated biomarkers of chronic inflammation and vascular injury that are also known to be affected by ambient air pollution.
BACKGROUND:Toxoplasma gondii is a protozoan parasite that infects cats as definitive hosts and other warm-blooded animals including humans as intermediate hosts. It forms infectious cysts in the brain, muscle and other tissues establishing life-long latent infection. Approximately 10% of the US population is infected. While latent infections are largely asymptomatic, they are associated with neurological deficits and elevated risks of neuropsychiatric diseases. METHODS: This cross-sectional epidemiological study investigated associations of T. gondii infections with biomarkers of inflammation and vascular injury: soluble intercellular adhesion molecule 1 (ICAM-1), soluble vascular cell adhesion molecule 1 (VCAM-1), C-reactive protein (CRP), and serum amyloid A (SAA). Serum samples from 694 adults in the Raleigh-Durham-Chapel Hill, North Carolina metropolitan area were tested for IgG antibody response to T. gondii, and for the above biomarkers using commercially available assays. RESULTS:T. gondii seroprevalence rate in this sample was 9.7%. Seropositivity was significantly associated with 11% (95% confidence limits 4, 20%) greater median levels of VCAM-1 (p = 0.003), and marginally significantly with 9% (1, 17%), and 36% (1, 83%) greater median levels of ICAM-1, and CRP, respectively (p = 0.04 for each) after adjusting for sociodemographic and behavioral covariates, while the 23% (- 7, 64%) adjusted effect on SAA was not statistically significant (p = 0.15). CONCLUSIONS: Latent infections with T. gondii are associated with elevated biomarkers of chronic inflammation and vascular injury that are also known to be affected by ambient air pollution.
Authors: Qila Sa; Eri Ochiai; Tomoko Sengoku; Melinda E Wilson; Morgan Brogli; Stephen Crutcher; Sara A Michie; Baohui Xu; Laura Payne; Xisheng Wang; Yasuhiro Suzuki Journal: Infect Immun Date: 2014-04-21 Impact factor: 3.441
Authors: Haydee A Dabritz; Melissa A Miller; E Robert Atwill; Ian A Gardner; Christian M Leutenegger; Ann C Melli; Patricia A Conrad Journal: J Am Vet Med Assoc Date: 2007-12-01 Impact factor: 1.936
Authors: Stephen Kaptoge; Emanuele Di Angelantonio; Lisa Pennells; Angela M Wood; Ian R White; Pei Gao; Matthew Walker; Alexander Thompson; Nadeem Sarwar; Muriel Caslake; Adam S Butterworth; Philippe Amouyel; Gerd Assmann; Stephan J L Bakker; Elizabeth L M Barr; Elizabeth Barrett-Connor; Emelia J Benjamin; Cecilia Björkelund; Hermann Brenner; Eric Brunner; Robert Clarke; Jackie A Cooper; Peter Cremer; Mary Cushman; Gilles R Dagenais; Ralph B D'Agostino; Rachel Dankner; George Davey-Smith; Dorly Deeg; Jacqueline M Dekker; Gunnar Engström; Aaron R Folsom; F Gerry R Fowkes; John Gallacher; J Michael Gaziano; Simona Giampaoli; Richard F Gillum; Albert Hofman; Barbara V Howard; Erik Ingelsson; Hiroyasu Iso; Torben Jørgensen; Stefan Kiechl; Akihiko Kitamura; Yutaka Kiyohara; Wolfgang Koenig; Daan Kromhout; Lewis H Kuller; Debbie A Lawlor; Tom W Meade; Aulikki Nissinen; Børge G Nordestgaard; Altan Onat; Demosthenes B Panagiotakos; Bruce M Psaty; Beatriz Rodriguez; Annika Rosengren; Veikko Salomaa; Jussi Kauhanen; Jukka T Salonen; Jonathan A Shaffer; Steven Shea; Ian Ford; Coen D A Stehouwer; Timo E Strandberg; Robert W Tipping; Alberto Tosetto; Sylvia Wassertheil-Smoller; Patrik Wennberg; Rudi G Westendorp; Peter H Whincup; Lars Wilhelmsen; Mark Woodward; Gordon D O Lowe; Nicholas J Wareham; Kay-Tee Khaw; Naveed Sattar; Chris J Packard; Vilmundur Gudnason; Paul M Ridker; Mark B Pepys; Simon G Thompson; John Danesh Journal: N Engl J Med Date: 2012-10-04 Impact factor: 91.245
Authors: Gabrielly Lisboa da Silva Soares; Ellen Rose Leandro Ponce de Leão; Sinara Franco Freitas; Raissa Maria Carvalho Alves; Naiana de Paula Tavares; Maria Vitória Nascimento Costa; Gabriel Castro de Menezes; Jhonnathan Henrique Palheta de Oliveira; Luma Cristina Ferreira Guerreiro; Alexa Camila Lopes de Assis; Sanderson Corrêa Araújo; Felipe Tuji de Castro Franco; Ana Karyssa Mendes Anaissi; Ediclei Lima do Carmo; Rafaela Dos Anjos Pinheiro Bogoevich Morais; Samia Demachki; José Antonio Picanço Diniz; Heloisa Marceliano Nunes; Daniel C Anthony; Daniel Guerreiro Diniz; Cristovam Wanderley Picanço Diniz Journal: Front Cell Infect Microbiol Date: 2022-03-09 Impact factor: 5.293